Efficacy and Safety of Treating Stage 2 Systolic Hypertension With Olmesartan and Olmesartan/HCTZ: Results of an Open‐Label Titration Study

समान संसाधन

• Titration of HCTZ to 50 mg Daily in Individuals With Stage 2 Systolic Hypertension Pretreated With an Angiotensin Receptor Blocker
  द्वारा: Izzo, Joseph L., और अन्य
  प्रकाशित: (2007)
• Comparison of Increasing Doses of Olmesartan Medoxomil, Losartan Potassium, and Valsartan in Patients With Essential Hypertension
  द्वारा: Giles, Thomas D., और अन्य
  प्रकाशित: (2007)
• A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension
  द्वारा: Cushman, William C., और अन्य
  प्रकाशित: (2018)
• Efficacy and Tolerability of Olmesartan, Telmisartan, and Losartan in Patients of Stage I Hypertension: A Randomized, Open-label Study
  द्वारा: Kalikar, Mrunalini, और अन्य
  प्रकाशित: (2017)
• Efficacy and Safety of Irbesartan/HCTZ Combination Therapy As Initial Treatment for Rapid Control of Severe Hypertension
  द्वारा: Neutel, Joel M., और अन्य
  प्रकाशित: (2007)